195 related articles for article (PubMed ID: 32029230)
1. Regulation of muscle and metabolic physiology by hypothalamic erythropoietin independently of its peripheral action.
Wang Z; Khor S; Cai D
Mol Metab; 2020 Feb; 32():56-68. PubMed ID: 32029230
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in muscles.
Hojman P; Brolin C; Gissel H; Brandt C; Zerahn B; Pedersen BK; Gehl J
PLoS One; 2009 Jun; 4(6):e5894. PubMed ID: 19521513
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin reduces fat mass in female mice lacking estrogen receptor alpha.
Lee J; Walter MF; Korach KS; Noguchi CT
Mol Metab; 2021 Mar; 45():101142. PubMed ID: 33309599
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice.
Kodo K; Sugimoto S; Nakajima H; Mori J; Itoh I; Fukuhara S; Shigehara K; Nishikawa T; Kosaka K; Hosoi H
PLoS One; 2017; 12(3):e0173661. PubMed ID: 28288167
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin Non-hematopoietic Tissue Response and Regulation of Metabolism During Diet Induced Obesity.
Dey S; Lee J; Noguchi CT
Front Pharmacol; 2021; 12():725734. PubMed ID: 34603036
[TBL] [Abstract][Full Text] [Related]
6. Sex-specific brain erythropoietin regulation of mouse metabolism and hypothalamic inflammation.
Dey S; Cui Z; Gavrilova O; Zhang X; Gassmann M; Noguchi CT
JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32078583
[TBL] [Abstract][Full Text] [Related]
7. The effects of erythropoietin dose titration during high-fat diet-induced obesity.
Foskett A; Alnaeeli M; Wang L; Teng R; Noguchi CT
J Biomed Biotechnol; 2011; 2011():373781. PubMed ID: 21541227
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin regulates metabolic response in mice via receptor expression in adipose tissue, brain, and bone.
Noguchi CT
Exp Hematol; 2020 Dec; 92():32-42. PubMed ID: 32950599
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin and Hypothalamic-Pituitary Axis.
Dey S; Noguchi CT
Vitam Horm; 2017; 105():101-120. PubMed ID: 28629513
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin-Induced Changes in Bone and Bone Marrow in Mouse Models of Diet-Induced Obesity.
Suresh S; Alvarez JC; Dey S; Noguchi CT
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121294
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 down-regulation in the mediobasal hypothalamus attenuates hypothalamic inflammation and protects against diet-induced obesity.
Mendes NF; Gaspar JM; Lima-Júnior JC; Donato J; Velloso LA; Araújo EP
Metabolism; 2018 Aug; 85():171-182. PubMed ID: 29660453
[TBL] [Abstract][Full Text] [Related]
12. Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesity.
Pascoal LB; Bombassaro B; Ramalho AF; Coope A; Moura RF; Correa-da-Silva F; Ignacio-Souza L; Razolli D; de Oliveira D; Catharino R; Velloso LA
J Neuroinflammation; 2017 Jan; 14(1):5. PubMed ID: 28086928
[TBL] [Abstract][Full Text] [Related]
13. Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production.
Teng R; Gavrilova O; Suzuki N; Chanturiya T; Schimel D; Hugendubler L; Mammen S; Yver DR; Cushman SW; Mueller E; Yamamoto M; Hsu LL; Noguchi CT
Nat Commun; 2011 Nov; 2():520. PubMed ID: 22044999
[TBL] [Abstract][Full Text] [Related]
14. Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice.
Coffey R; Sardo U; Kautz L; Gabayan V; Nemeth E; Ganz T
Physiol Rep; 2018 Sep; 6(19):e13890. PubMed ID: 30315639
[TBL] [Abstract][Full Text] [Related]
15. Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IkappaB kinase beta (IKKbeta)/NF-kappaB pathway.
Meng Q; Cai D
J Biol Chem; 2011 Sep; 286(37):32324-32. PubMed ID: 21784844
[TBL] [Abstract][Full Text] [Related]
16. Chronic erythropoietin treatment improves diet-induced glucose intolerance in rats.
Caillaud C; Mechta M; Ainge H; Madsen AN; Ruell P; Mas E; Bisbal C; Mercier J; Twigg S; Mori TA; Simar D; Barrès R
J Endocrinol; 2015 May; 225(2):77-88. PubMed ID: 25767056
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic integration of immune function and metabolism.
Guijarro A; Laviano A; Meguid MM
Prog Brain Res; 2006; 153():367-405. PubMed ID: 16876587
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hypothalamic leukemia inhibitory factor exacerbates diet-induced obesity phenotype.
Fioravante M; Bombassaro B; Ramalho AF; Dragano NR; Morari J; Solon C; Tobar N; Ramos CD; Velloso LA
J Neuroinflammation; 2017 Sep; 14(1):178. PubMed ID: 28865476
[TBL] [Abstract][Full Text] [Related]
19. Dietary flavonoid kaempferol reduces obesity-associated hypothalamic microglia activation and promotes body weight loss in mice with obesity.
Romero-Juárez PA; Visco DB; Manhães-de-Castro R; Urquiza-Martínez MV; Saavedra LM; González-Vargas MC; Mercado-Camargo R; Aquino JS; Toscano AE; Torner L; Guzmán-Quevedo O
Nutr Neurosci; 2023 Jan; 26(1):25-39. PubMed ID: 34905445
[TBL] [Abstract][Full Text] [Related]
20. Perturbation of hypothalamic microRNA expression patterns in male rats after metabolic distress: impact of obesity and conditions of negative energy balance.
Sangiao-Alvarellos S; Pena-Bello L; Manfredi-Lozano M; Tena-Sempere M; Cordido F
Endocrinology; 2014 May; 155(5):1838-50. PubMed ID: 24517225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
